Patients with mesothelioma may be getting a new second-line treatment, thanks to results from a recent immunotherapy trial. For patients with malignant pleural mesothelioma — which makes up about 90 ...

WASHINGTON – People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the ...

Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes to the updated recommendations across topics ...

An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results ...

SAN MATEO, Calif., July 30, 2025 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, ...

Keytruda and Lenvima combination shows promising results for pleural mesothelioma after chemotherapy failure, with a 58% objective response rate. The PEMMELA trial reported a median progression-free ...

Our Mesothelioma Options Help Centers have a network of top doctors and surgeons from coast to coast. The Steinberg Law Group has decades of proven experience and the resources to help victims of ...

We support our military veterans. The Mesothelioma Options Help Center can help you find the best doctors and treatments from coast to coast. The Steinberg Law Group has decades of proven experience ...